Drug · DIN 02439026
TACHOSIL
2.5 CM X 3 CM
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 25, 2022.
- Drug Identification Number (DIN)
- 02439026
- Company (DIN owner)
- Corza Medical GmbhDusseldorf, Nordrhein-Westfalen, Germany
- Schedule
- Schedule D
- Dosage form
- Patch
- Route
- Topical
- Therapeutic class (ATC)
- Combinations B02BC30
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FIBRINOGEN (HUMAN) | 5.5 MG | SQ CM |
| THROMBIN (HUMAN) | 2 UNIT | SQ CM |
| COLLAGEN | 2.1 MG | SQ CM |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 25, 2022: NOC 27673Supplement to a New Drug Submission (SNDS) · Administrative ¿ Transfer of Drug Identification Number (DIN); Labelling updates
- March 26, 2015: NOC 16719New Drug Submission (NDS)
Other DINs named TACHOSIL
- DIN 02439034 · Approved
- DIN 02439042 · Dormant